Renaissance Technologies’s Capricor Therapeutics CAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-137,500
Closed -$656K 3550
2024
Q2
$656K Buy
137,500
+84,350
+159% +$402K ﹤0.01% 2556
2024
Q1
$361K Sell
53,150
-93,171
-64% -$633K ﹤0.01% 3004
2023
Q4
$716K Buy
146,321
+103,700
+243% +$507K ﹤0.01% 2589
2023
Q3
$146K Sell
42,621
-3,800
-8% -$13K ﹤0.01% 3163
2023
Q2
$222K Buy
46,421
+15,900
+52% +$76K ﹤0.01% 3260
2023
Q1
$129K Buy
30,521
+7,500
+33% +$31.7K ﹤0.01% 3410
2022
Q4
$89K Buy
23,021
+12,821
+126% +$49.6K ﹤0.01% 3654
2022
Q3
$61K Buy
+10,200
New +$61K ﹤0.01% 3705
2020
Q3
Sell
-198,800
Closed -$914K 3395
2020
Q2
$914K Buy
198,800
+95,185
+92% +$438K ﹤0.01% 2580
2020
Q1
$124K Buy
103,615
+19,830
+24% +$23.7K ﹤0.01% 3186
2019
Q4
$107K Buy
83,785
+43,272
+107% +$55.3K ﹤0.01% 3307
2019
Q3
$150K Buy
+40,513
New +$150K ﹤0.01% 3208